Fadinosine (Fadinosin)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceDidanosineDidanosine
Similar drugsTo uncover
  • Videx®
    capsules inwards 
    Bristol-Myers Squibb Company     USA
  • Videx®
    powder inwards 
    Bristol-Myers Squibb Company     USA
  • Didanosine
    capsules inwards 
    Aurobindo Pharma Co., Ltd.     India
  • Didanosine-native
    powder inwards 
    NATIVA, LLC     Russia
  • Fadinosine
    capsules inwards 
    FARMASINTEZ, JSC (Irkutsk)     Russia
    • Dosage form: & nbspenteric-coated capsules
    ATX: & nbsp

    J.05.A.F.02   Didanosine

    Terms of leave from pharmacies:On prescription
    Registration number:LP-004805
    Date of registration:19.04.2018
    Expiration Date:19.04.2023
    The owner of the registration certificate:FARMASINTEZ, JSC (Irkutsk) FARMASINTEZ, JSC (Irkutsk) Russia
    Manufacturer: & nbsp
    Information update date: & nbsp22.05.2018
    Illustrated instructions
      Instructions
      Up